Chicago Atlantic BDC (LIEN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Nov, 2025Executive summary
Focused on lending to cannabis and other highly regulated industries, primarily through senior secured, first lien loans, with a differentiated risk-reward profile among BDCs.
Completed a major loan portfolio acquisition in October 2024, significantly increasing asset base and scale.
As of March 31, 2025, the investment portfolio had a fair value of $289.3 million across 31 companies, with 79% exposure to the cannabis sector.
Declared a $0.34 dividend for Q1 and Q2 2025, totaling $1.27 over the last four quarters.
No loans on non-accrual status as of quarter end.
Financial highlights
Gross/total investment income for Q1 2025 was $11.9 million, down from $12.7 million in Q4 2024, and up from $2.8 million in Q1 2024.
Net investment income was $7.6 million ($0.34 per share), compared to $8 million ($0.35 per share) last quarter.
Net assets at quarter-end were $301 million, with NAV per share at $13.19.
22.8 million common shares outstanding on a basic and fully diluted basis.
Principal repayments during Q1 2025 totaled $7.6 million.
Outlook and guidance
Management expects to ramp capital deployment, focusing on proven operators, strong markets, and robust collateral coverage.
Pipeline includes $590 million in potential debt transactions across 35 companies.
No significant change in deployment mix between cannabis and non-cannabis expected.
Dividend increases not guided, but all income will be distributed by year-end as required.
Adviser remains focused on conservative credit profile and lender-friendly terms.
Latest events from Chicago Atlantic BDC
- NAV per share fell to $13.56 as a $130M+ loan portfolio acquisition approaches.LIEN
Q2 20242 Feb 2026 - $219.6M loan portfolio acquisition tripled net assets and expanded diversification.LIEN
Q3 202415 Jan 2026 - Cannabis lending offers unique risk-reward and is poised for growth as capital markets evolve.LIEN
Fireside chat13 Jan 2026 - Q4 and FY24 saw portfolio expansion, 36% dividend growth, and a $100M credit facility.LIEN
Q4 202427 Dec 2025 - Annual meeting to vote on board re-election and auditor, with focus on cannabis lending.LIEN
Proxy Filing2 Dec 2025 - Vote on board re-election and auditor ratification at the June 2025 virtual annual meeting.LIEN
Proxy Filing2 Dec 2025 - Annual meeting to vote on director re-election and auditor ratification, with Board support.LIEN
Proxy Filing2 Dec 2025 - Q2 2025 saw strong income, high yields, and robust liquidity, fueling continued portfolio growth.LIEN
Q2 202523 Nov 2025 - Q3 2025 saw record originations, strong income, high cannabis exposure, and robust liquidity.LIEN
Q3 202517 Nov 2025